跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE
Approved
STANDARD
RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE
Ipsen Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 13, 2024
Approval ID
c1fdfe3bebe0a5c7
Company
Ipsen Pharma
Type
Standard
Approval Details
Approval Id
c1fdfe3bebe0a5c7
Drug Cima Aemps Name
RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE
Register Number
89758
Holder Company Name
Ipsen Pharma
Marketing Company Name
Laboratorios Galderma S.A.
Holder Company Detail Path
/organization/ipsen-pharma
Authorization Date
2024-09-13
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 U/ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Ipsen Pharma
Company Detail Path
/organization/ipsen-pharma
Company Information
Pharmaceutical Company Name
IPSEN PHARMA
Country Name
France
City Name
boulogne-billancourt,ile de france,country_fr
Address
65 QUAI GEORGES GORSE
Active Ingredients
TOXINA BOTULINICA TIPO A
150 U
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 13, 2024
Approval ID
c1fdfe3bebe0a5c7
Type
Standard
Back to CIMA-AEMPS Approvals
RELFYDESS 100 UNIDADES/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
